[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ligand Pharm (LGND)

Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,891,854
  • Shares Outstanding, K 20,041
  • Annual Sales, $ 268,090 K
  • Annual Income, $ 124,450 K
  • EBIT $ 127 M
  • EBITDA $ 157 M
  • 60-Month Beta 1.10
  • Price/Sales 22.68
  • Price/Cash Flow 38.64
  • Price/Book 6.10

Options Overview Details

View History
  • Implied Volatility 47.64% (-1.27%)
  • Historical Volatility 39.60%
  • IV Percentile 85%
  • IV Rank 42.25%
  • IV High 73.14% on 04/13/26
  • IV Low 28.98% on 08/08/25
  • Expected Move (DTE 31) 10.68 (3.49%)
  • Put/Call Vol Ratio 1.17
  • Today's Volume 13
  • Volume Avg (30-Day) 80
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 1,159
  • Open Int (30-Day) 1,291
  • Expected Range 294.79 to 316.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.23
  • Number of Estimates 3
  • High Estimate $1.63
  • Low Estimate $1.01
  • Prior Year $0.24
  • Growth Rate Est. (year over year) +412.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
245.00 +24.68%
on 06/22/26
326.63 -6.48%
on 07/08/26
+30.59 (+11.13%)
since 06/18/26
3-Month
200.01 +52.73%
on 05/07/26
326.63 -6.48%
on 07/08/26
+78.80 (+34.76%)
since 04/21/26
52-Week
129.55 +135.79%
on 08/01/25
326.63 -6.48%
on 07/08/26
+164.35 (+116.46%)
since 07/21/25

Most Recent Stories

More News
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

Acquisition adds seven  commercial products including VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafenib), and MIPLYFFA® (arimoclomol), and more than 100 development and commercial-stage assets,...

LGND : 305.47 (+3.90%)
XOMA Royalty Announces Closing of Its Acquisition by Ligand

EMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has completed its previously announced acquisition...

XOMA : 40.17 (-9.16%)
LGND : 305.47 (+3.90%)
XOMAP : 24.98 (+0.04%)
XOMAO : 25.00 (+0.08%)
3 Overlooked Stocks Positioned for the Next Market Rotation

Oxford Club strategist Marc Lichtenfeld highlights diversification beyond tech, spotlighting Ligand Pharmaceuticals, Aflac and Atlantic Union Bankshares as healthcare, insurance and banking stocks gaining...

LGND : 305.47 (+3.90%)
AFL : 123.59 (-0.39%)
AUB : 42.81 (+1.86%)
Ligand Announces Closing of Convertible Senior Notes Offering

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset...

LGND : 305.47 (+3.90%)
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset...

LGND : 305.47 (+3.90%)
Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.19%. September...

GOOGL : 347.15 (-1.38%)
AAPL : 327.74 (+0.35%)
SNDK : 1,589.40 (+14.27%)
ADI : 382.81 (+2.78%)
TSLA : 378.93 (+2.53%)
STX : 891.83 (+11.14%)
AMD : 544.43 (+8.11%)
DFTX : 45.08 (+5.33%)
SPY : 748.28 (+0.83%)
META : 643.81 (-0.32%)
NOC : 512.29 (-2.23%)
FRVO : 26.99 (+5.88%)
Stocks Erase Early Gains as Alphabet and Software Companies Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.40%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. September E-mini S&P futures...

MSTR : 101.95 (+4.22%)
GOOGL : 347.15 (-1.38%)
SNDK : 1,589.40 (+14.27%)
COIN : 175.85 (+9.61%)
STX : 891.83 (+11.14%)
AMD : 544.43 (+8.11%)
DFTX : 45.08 (+5.33%)
^BTCUSD : 66,381.86 (+0.10%)
SPY : 748.28 (+0.83%)
NOC : 512.29 (-2.23%)
FRVO : 26.99 (+5.88%)
ADSK : 211.15 (-3.05%)
Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.50%. September E-mini S&P futures...

MSTR : 101.95 (+4.22%)
AMAT : 564.55 (+7.39%)
GOOGL : 347.15 (-1.38%)
SNDK : 1,589.40 (+14.27%)
GLXY : 25.41 (+7.40%)
$IUXX : 29,155.18 (+1.93%)
COIN : 175.85 (+9.61%)
ZNU26 : 108-205 (unch)
LGND : 305.47 (+3.90%)
APGE : 134.20 (+0.04%)
ESU26 : 7,541.25 (-0.06%)
STX : 891.83 (+11.14%)
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

Opportunistic capital raise with proceeds used to enhance financial flexibility  A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to...

LGND : 305.47 (+3.90%)
Ligand Announces 2026 Investor Day in New York City

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 8, 2026 at...

LGND : 305.47 (+3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated...

See More

Key Turning Points

3rd Resistance Point 318.96
2nd Resistance Point 312.22
1st Resistance Point 308.84
Last Price 305.47
1st Support Level 298.72
2nd Support Level 291.98
3rd Support Level 288.60

See More

52-Week High 326.63
Last Price 305.47
Fibonacci 61.8% 251.35
Fibonacci 50% 228.09
Fibonacci 38.2% 204.83
52-Week Low 129.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.